GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Symmetry Surgical Inc (FRA:RZV) » Definitions » EV-to-Revenue

Symmetry Surgical (FRA:RZV) EV-to-Revenue : 0.90 (As of Jun. 24, 2024)


View and export this data going back to . Start your Free Trial

What is Symmetry Surgical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Symmetry Surgical's enterprise value is €270.9 Mil. Symmetry Surgical's Revenue for the trailing twelve months (TTM) ended in Sep. 2014 was €302.1 Mil. Therefore, Symmetry Surgical's EV-to-Revenue for today is 0.90.

The historical rank and industry rank for Symmetry Surgical's EV-to-Revenue or its related term are showing as below:

FRA:RZV' s EV-to-Revenue Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 1.18

FRA:RZV's EV-to-Revenue is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 3.02 vs FRA:RZV: 1.18

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-24), Symmetry Surgical's stock price is €7.81. Symmetry Surgical's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2014 was €8.22. Therefore, Symmetry Surgical's PS Ratio for today is 0.95.


Symmetry Surgical EV-to-Revenue Historical Data

The historical data trend for Symmetry Surgical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Symmetry Surgical EV-to-Revenue Chart

Symmetry Surgical Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.01 1.14 1.52 1.44 1.34

Symmetry Surgical Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.20 1.34 1.33 1.20 1.29

Competitive Comparison of Symmetry Surgical's EV-to-Revenue

For the Medical Devices subindustry, Symmetry Surgical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Symmetry Surgical's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Symmetry Surgical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Symmetry Surgical's EV-to-Revenue falls into.



Symmetry Surgical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Symmetry Surgical's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=270.929/302.117
=0.90

Symmetry Surgical's current Enterprise Value is €270.9 Mil.
Symmetry Surgical's Revenue for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €302.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Symmetry Surgical  (FRA:RZV) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Symmetry Surgical's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=7.81/8.22
=0.95

Symmetry Surgical's share price for today is €7.81.
Symmetry Surgical's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €8.22.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Symmetry Surgical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Symmetry Surgical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Symmetry Surgical (FRA:RZV) Business Description

Traded in Other Exchanges
N/A
Address
Symmetry Medical, Inc., is a Delaware corporation incorporated on July 25, 1996. It is a source of medical device products. The Company provides medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry and other medical device markets. It also manufactures specialized non-healthcare products, mainly in the aerospace industry. It operates in two reportable segments namely Original Equipment Manufacturer (OEM) Solutions and Symmetry Surgical. Its main products produced in the OEM Solutions segment include: implants, including forged, cast and machined products for the global orthopedic device market; instruments used in the placement and removal of orthopedic implants and in other surgical procedures; cases, including plastic, metal and hybrid cases used to organize, secure and transport medical devices for orthopedic, endoscopy, dental and other surgical procedures; and other specialized products for the aerospace market. Symmetry Surgical is its new business segment. It arose from the integration of the Codman and Olsen Medical lines of surgical instruments with its Company's already existing hospital direct business, Specialty Surgical Instrumentation (SSI). Symmetry Surgical, which is headquartered in Nashville, Tennessee offers reusable stainless steel and titanium surgical hand-held instruments and retractor systems, sterile disposable surgical products, and sterilization containers. These products are used in the surgical specialties of spine, general/obstetrics/gynecology, microsurgery/neurosurgery, orthopedics, and laparoscopy, cardiovascular, thoracic and general surgery in the hospital setting as well as surgery centers and in select physician offices. The Company's OEM Solutions segment has manufacturing facilities in the U.S., United Kingdom, France, Ireland and Malaysia. The Company's subject to federal, state and local environmental laws and regulations governing the emission, discharge, use, storage and disposal of hazardous materials and the remediation of contamination associated with the release of these materials at our facilities and at off-site disposal locations.

Symmetry Surgical (FRA:RZV) Headlines